Comparative effectiveness of magnetic resonance (MR) imaging in women with breast cancer

Hull and East Yorkshire Hospitals NHS Trust (UK)0 个研究点目标入组 1,623 人开始时间: 2002年6月19日最近更新: 2022年11月7日

适应症

试验速览

2010 Results article in http://www.ncbi.nlm.nih.gov/pubmed/20025837 results on cost effectiveness 2010 Results article in http://www.ncbi.nlm.nih.gov/pubmed/20159292 results on clinical effectiveness

•Added as of 10/06/2008:
•1. Medically unstable
•2. Known contraindication to magnetic resonance (MR) scanning
•3. Known to have had an allergic reaction associated with previous administration of paramagnetic contrast agent or have a severe allergic diathesis
•4. Require renal dialysis
•5. Have undergone chemotherapy/ hormonal therapy for cancer of the contralateral breast (or other sites) in the previous 12 months or have chemotherapy planned to any site before their breast surgery
•6. Have had surgery or radiotherapy for cancer to the ipsilateral breast
•7. Have had surgery to the ipsilateral breast within the previous 4 months for benign breast disease
•8. Have a history of serious breast trauma within the last 3 months
•9. Pregnant or breast feeding
•10. Disability preventing MR scanning in the prone position
•11. Under the care of a breast surgeon recruiting into the ALMANAC Trial

发起方

Hull and East Yorkshire Hospitals NHS Trust (UK)